Peer-reviewedCC BYFrontiers in microbiology
Gut microbiota-derived tryptophan metabolites in cardiovascular disease: mechanisms, biomarkers, and precision interventions
4 affiliations
- 1Shanghai Fourth People's Hospital, School of Medicine, Tongji University , ,
- 2Department of Cardiology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University , ,
- 3Leiden University Medical Center, Eindhoven Laboratory, Leiden University , ,
- 4Edinburgh Medical School: Biomedical Sciences, College of Medicine and Veterinary Medicine, University of Edinburgh , ,
Related
- Gut microbiota–derived tryptophan metabolites: molecular mechanisms, nutritional strategies and implications for swine health
- Immunomodulatory mechanisms of gut microbiota-derived metabolites in non-small cell lung cancer: a gut–lung axis perspective
- Tryptophan-driven metabolomic shift in Acidobacteriaceae reveals phytohormones and antifungal metabolites
- Maternal gut microbiota, tryptophan metabolism and immune homeostasis: Implications for the prevention of adverse pregnancy complications
- Tryptophan metabolism and plant health: mechanisms of action and application prospects
BibTeX
@article{ding2026microbiotaderived,
title = {{Gut microbiota-derived tryptophan metabolites in cardiovascular disease: mechanisms, biomarkers, and precision interventions}},
author = {Qian Ding and Siqi Li and Mu Guo and Jia Pu and Jun Wei and Wei Chen},
journal = {Frontiers in microbiology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13659223},
note = {CC BY},
}
RIS
TY - JOUR
TI - Gut microbiota-derived tryptophan metabolites in cardiovascular disease: mechanisms, biomarkers, and precision interventions
AU - Qian Ding
AU - Siqi Li
AU - Mu Guo
AU - Jia Pu
AU - Jun Wei
AU - Wei Chen
PY - 2026
DA - 2026/10/16
JO - Frontiers in microbiology
UR - https://europepmc.org/article/PMC/PMC13659223
SN - 1664-302X
ER -